The STT3B gene helps cells attach sugar tags to certain proteins, a step that supports proper folding and function. This gene helps your body process proteins that might otherwise be finished incorrectly. When the gene does not work well, some people have a rare congenital disorder of glycosylation, which can affect development, muscle tone, feeding, seizures, and clotting or liver function. Effects can vary from person to person.
What is a gene?
A gene is a section of DNA that carries information your cells use to make molecules or regulate processes in the body. Some genes provide the instructions for producing proteins, which are the working parts of cells. Others mainly help direct when certain processes happen, where they happen, and how strongly they are carried out. Taken together, genes affect how the body grows and works, and they can also influence how you respond to food, stress, or medicines. For a deeper look at this topic, you can find more in the LearnHub.
Overview
STT3BGene function
What if the gene works
The STT3B gene helps cells attach sugar chains to many newly made proteins. This step supports proper protein folding, stability, and movement through the cell.
Risk
What if the gene does not work
Variants in the STT3B gene can cause a congenital disorder of glycosylation, often with developmental delay, low muscle tone, seizures, and growth or feeding problems. Milder and more severe variants may affect when features appear and how marked they are.
Treatment
What does that mean for your treatment
No STT3B-specific treatment or management approach is currently established for people with a pathogenic or loss-of-function variant in the STT3B gene. In early research, the STT3B gene is being studied as a possible drug target in some cancers through medicines that affect glycosylation (the process of adding sugar groups to proteins).
Conditions associated with STT3B
Gene function
What if the gene works
Inside your cells, the STT3B gene helps add small sugar chains to many newly made proteins. This step helps proteins finish maturing, fold into shape, and get ready for where they need to go. It is especially helpful for catching protein sites that were not tagged during the earliest stage of processing.
The STT3B gene helps place sugar chains onto certain newly made proteins in the endoplasmic reticulum (the cell's protein finishing area). This is part of protein glycosylation in the endoplasmic reticulum, which helps proteins mature in a controlled way.
One of its main roles is to add sugar tags to protein sites that were missed earlier in processing. This later step helps complete the finishing of proteins that were not fully tagged the first time.
These sugar tags help many proteins fold into their usual shape and stay stable while the cell checks them. That supports smooth handling of proteins before they move onward to the cell surface or outside the cell.
By helping complete these sugar additions, the STT3B gene supports normal sorting of many membrane and secreted proteins. This helps proteins reach the right place for their everyday work.
What is a variant?
Genetic variants are small differences in the DNA sequence within a gene. They are common and help explain normal human diversity, including differences in appearance, metabolism, and how the body responds to environmental influences. Many do not cause any noticeable effects and are part of natural genetic variation. Sometimes, though, a variant can change how a gene works more significantly and may contribute to or lead to a genetic condition.
Genetic variants
What if the gene does not work
Variants in the STT3B gene can weaken or disrupt the protein’s ability to add sugar chains to certain proteins, especially late in cell processing. This helps explain how STT3B gene variants affect protein glycosylation, with some proteins left incompletely modified. Milder variants may partly reduce protein stability or activity, while more severe variants can greatly impair activity or prevent the protein from working properly within its larger cell complex.
How variants are linked to conditions
Certain variants in the STT3B gene can cause a rare inherited condition called STT3B-CDG, a type of congenital disorder of glycosylation (a condition that affects how the body modifies many proteins). Reported features include developmental delay, intellectual disability, low muscle tone, seizures, and eye findings, although not everyone is affected in the same way. Information on STT3B gene variants and health conditions is still growing, but a confirmed disease-causing variant can establish the diagnosis.
A variant is not necessarily a diagnosis
Gene variants are a normal feature of human biology and are common across the general population. Most do not have a direct impact on health and simply reflect natural human diversity. In many genes, carrying a variant connected with a condition indicates a possible association rather than a confirmed diagnosis, especially when several genes and environmental factors contribute. In some situations, though, a single well-characterized variant in a particular gene is enough to confirm a diagnosis.
Are there things that can increase or change my risk?
There is not yet broadly confirmed evidence on specific factors that increase or reduce health risk related to the STT3B gene. In most cases, any impact comes mainly from the particular genetic change itself rather than lifestyle or everyday exposures, and personal risk is best discussed with a doctor or genetic counselor.
Inheritance of STT3B variants
STT3B-related conditions are inherited in an autosomal recessive pattern. In practical terms, how STT3B gene variants are inherited usually means a child needs to receive one altered copy of the STT3B gene from each parent to have the condition. When both parents are carriers, each pregnancy has a 25% chance of the child being affected, a 50% chance of the child being an unaffected carrier, and a 25% chance of the child inheriting two working copies. Parents of an affected child are usually healthy carriers.
What does my STT3B result mean for my family?
For STT3B, family impact is usually discussed in the setting of a rare inherited condition passed down in a recessive way. This often means parents carry one changed copy without having the condition, while brothers and sisters may also be affected or may be carriers. Other close relatives could be carriers too, so the result may matter beyond one person in the family.
Genetic information
Genetic testing
How you find out about variants
To find out whether you carry a variant in the STT3B gene, genetic testing analyzes DNA from a blood sample, saliva, or cheek swab. STT3B genetic testing may be done as part of a multigene panel, exome sequencing, or whole genome sequencing, and the lab compares your DNA with a reference sequence to look for meaningful changes.
When should I consider getting a genetic test?
Genetic testing for the STT3B gene may be considered when a child has unexplained developmental delay, low muscle tone, seizures, or lab findings that suggest a rare inherited problem with protein processing. It can also help if similar problems run in the family or more than one child is affected.
A genetic result is only one part of your health story
A genetic result can provide useful insight, but how much it reveals depends on the condition and the kind of variant involved. Over time, many factors, including lifestyle, environment, age, and medical history, influence how the body functions. In some conditions, especially those shaped by many genes, genetic information provides context rather than certainty and is most helpful when viewed alongside other parts of care. In other situations, a genetic result can offer a clear answer. In areas such as medication response, genetic results can help put individual experiences into context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. Small differences in a person’s DNA can change how the body absorbs, breaks down, transports, or responds to a drug. This helps explain why the same treatment may work well for one person, seem weaker in another, or cause more side effects in someone else. These differences are common and are one reason medication response can vary from person to person.
What is Pharmacogenetics?
Pharmacogenetics examines how genetic differences can shape a person’s response to medications. It studies the links between genes and drugs to better understand why the same treatment can work differently from one person to another. For many medicines, genes influence how strongly a drug works or how the body processes it. This information can help support more informed, individualized treatment decisions. You can learn more about this topic in the LearnHub.
Drugs influenced by the STT3B gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in predicting how medicines will work or which side effects they may cause. If you have new symptoms, concerns about a health condition, or questions about any medicine or supplement, speak with your doctor or pharmacist.